These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31013360)

  • 21. Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.
    Scilla KA; Zandberg DP; Bentzen SM; Mainor C; Heath J; Ioffe OB; Cellini AL; Edelman MJ; Riedel DJ; Feliciano JL
    Lung Cancer; 2018 Sep; 123():87-90. PubMed ID: 30089601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.
    Inaguma S; Wang Z; Lasota J; Sarlomo-Rikala M; McCue PA; Ikeda H; Miettinen M
    Am J Surg Pathol; 2016 Aug; 40(8):1133-42. PubMed ID: 27158757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1 and B7-H3 are Effective Prognostic Factors and Potential Therapeutic Targets for High-Risk Thyroid Cancer.
    Zhu X; Hu C; Zhang Z; Zhu Y; Liu W; Zheng B; Feng X; Lu H
    Endocr Pathol; 2024 Sep; 35(3):230-244. PubMed ID: 39102163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN).
    Mangili G; Sabetta G; Cioffi R; Rabaiotti E; Candotti G; Pella F; Candiani M; Bergamini A
    Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma.
    He HX; Gao Y; Fu JC; Zhou QH; Wang XX; Bai B; Li PF; Huang C; Rong QX; Ping LQ; He YX; Mao JY; Chen X; Huang HQ
    Oncoimmunology; 2021 Apr; 10(1):1907059. PubMed ID: 33889438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
    Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
    Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
    [No Abstract]   [Full Text] [Related]  

  • 29. B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma.
    Lu Z; Zhao ZX; Cheng P; Huang F; Guan X; Zhang MG; Chen HP; Liu Z; Jiang Z; Zheng ZX; Zou SM; Wang XS
    Mod Pathol; 2020 Nov; 33(11):2330-2340. PubMed ID: 32514163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma.
    Long L; Zhang L; Yang Y; Zhou Y; Chen H
    Immunotherapy; 2022 Apr; 14(6):419-431. PubMed ID: 35187955
    [No Abstract]   [Full Text] [Related]  

  • 31. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
    Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
    Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities.
    Horowitz NS; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 2017 Jan; 144(1):208-214. PubMed ID: 27789086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental site and epithelioid trophoblastic tumours: diagnostic pitfalls.
    Moutte A; Doret M; Hajri T; Peyron N; Chateau F; Massardier J; Duvillard P; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Mar; 128(3):568-72. PubMed ID: 23159816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
    Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
    Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis.
    Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X
    Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of gestational trophoblastic disease in the 2020s.
    Clark JJ; Slater S; Seckl MJ
    Curr Opin Obstet Gynecol; 2021 Feb; 33(1):7-12. PubMed ID: 33337613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.
    Xie S; Huang J; Qiao Q; Zang W; Hong S; Tan H; Dong C; Yang Z; Ni L
    Cancer Immunol Immunother; 2018 Nov; 67(11):1685-1694. PubMed ID: 30128738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma.
    Chen Y; Hu R; Li X; Shi Z; Tian H; Feng J; Yu S
    Pathol Res Pract; 2020 Oct; 216(10):153134. PubMed ID: 32853956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer.
    Zong L; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
    Qin X; Sun W; Wang C; Li M; Zhao X; Li C; Zhang H
    Reprod Biol Endocrinol; 2021 Jul; 19(1):114. PubMed ID: 34289871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.